Known hypersensitivity. Concomitant administration with MAO inhibitors has been considered an absolute contraindication; however, patients with refractory depression have received combination therapy without significant adverse effects if used in combination therapy, give the drugs orally, avoid large doses and monitor the patient closely. Not recommended during the acute recovery phase following myocardial infarction, and in the presence of acute congestive heart failure.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign Out
